Prevention of Adriamycin Toxicity
Overview
Authors
Affiliations
Mice treated with lethal doses of adriamycin (A1) (IP) are rescued with a single IP dose of 3,5,5-trimethyl-2-morpholinon-3-yl radical dimer (TM3). The in vivo rescue is assumed to be analogous to the in vitro reaction of TM3 with A1 that produces the non-toxic 7-deoxy-adriamycinone (7dAone). TM3 prevents death if given within 60 min following A1 administration. Control A1-treated mice died by 8 days (median survival time) whereas TM3 rescued A1-treated mice had a median survival time of greater than 60 days.
A chemical perspective on the anthracycline antitumor antibiotics.
Abdella B, Fisher J Environ Health Perspect. 1985; 64:4-18.
PMID: 3913602 PMC: 1568615. DOI: 10.1289/ehp.85644.
Anthracycline antitumour agents. A review of physicochemical, analytical and stability properties.
Bouma J, Beijnen J, Bult A, Underberg W Pharm Weekbl Sci. 1986; 8(2):109-33.
PMID: 3520474 DOI: 10.1007/BF02086146.
Averbuch S, Boldt M, Gaudiano G, Stern J, Koch T, Bachur N J Clin Invest. 1988; 81(1):142-8.
PMID: 3121673 PMC: 442485. DOI: 10.1172/JCI113285.